1887

Abstract

Amino acids 731–752 (PRGPDRPEGIEEEGGERD- RDRS) of the transmembrane glycoprotein gp41 of human immunodeficiency virus type 1 (HIV-1)are conserved in most virus isolates and are controversially reported to be implicated in virus neutralization. The humoral response in infected patients against this region is poor and humans immunized with gp160 show high levels of antibodies against the peptide but poor neutralization titres. Nonetheless, several groups have succeeded in obtaining neutralizing antibodies against this sequence using different antigen-presenting systems. In order to identify the sequence(s) against which the neutralizing response was generated, we used the flock house virus (FHV) antigen-presenting system to analyse neutralizing antisera from mice immunized with a cowpea mosaic virus (CPMV) chimera expressing the 731–752 sequence. Data show that the neutralizing response is uniquely directed against a conformational epitope mapping to the ERDRD portion of this sequence, although the major antibody response, which is non-linear, and is not neutralizing, is against an IEEE epitope. These results provide an explanation for the controversy regarding the immunogenicity of this region of gp41 and suggest that this conformational epitope, in the absence of the non-neutralizing epitope, should be considered for a subunit vaccine. In addition, this study highlights the usefulness of antigen- presenting systems that preserve epitope conformation in the investigation of immune responses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-11-2709
1998-11-01
2022-08-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/11/9820146.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-11-2709&mimeType=html&fmt=ahah

References

  1. Amit A., Mariuzza R. A., Phillips S. E. V., Poljak R. J. 1986; Three-dimensional structure of an antigen-antibody complex at 2·8 Å resolution. Science 233:747–753
    [Google Scholar]
  2. Broliden P.-A., Von Gegerfelt A., Clapham P., Rosen J., Fenyo E.-M., Wahren B., Broliden K. 1992; Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proceedings of the National Academy of Sciences, USA 89:461–465
    [Google Scholar]
  3. Buratti E., Tisminetzky S. G., Scodeller E. S., Baralle F. E. 1996; Conformational display of two neutralizing epitopes of HIV-1 gp41 on the flock house virus capsid protein. Journal of Immunological Methods 197:7–18
    [Google Scholar]
  4. Buratti E., Tisminetzky S. G., D’Agaro P., Baralle F. E. 1997; A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE. Journal of Virology 71:2457–2462
    [Google Scholar]
  5. Chanh T. C., Dreesman G. R., Kanda P., Linette G. P., Sparrow J. T., Ho D. D., Kennedy R. C. 1986; Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO Journal 5:3065–3071
    [Google Scholar]
  6. Cheinsong-Popov R., Callow D., Beddows S., Shaunak S., Wasi C., Kalcebu P., Gilks C., Petrascu I. V., Garaev M. M., Watts D. M., Constantine N. T., Weber J. N. 1992; Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to Env epitopes and relationship to neutralization. Journal of Infectious Diseases 165:256–261
    [Google Scholar]
  7. Chen Y. H., Dierich M. P. 1996; Identification of a second site in HIV-1 gp41 mediating binding to cells. Immunology Letters 52:153–156
    [Google Scholar]
  8. Dalgleish A. G., Chanh T. C., Kennedy R. C., Kanda P., Clapham P. R., Weiss R. A. 1988; Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165:209–215
    [Google Scholar]
  9. Davis D., Chaudhri B., Stephens D. M., Carne C. A., Willers C., Lachmann P. J. 1990; The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host’s previous exposure to similar epitopes on unrelated antigens. Journal of General Virology 71:1975–1983
    [Google Scholar]
  10. Evans D. J., McKeating J., Meredith J. M., Burke K. L., Katrak K., John A., Ferguson M., Minor P. D., Weiss R. A., Almond J. W. 1989; An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339:385–388
    [Google Scholar]
  11. Gallagher D. M. 1992; HIV/AIDS: the epidemic continues. Imprint 39:62
    [Google Scholar]
  12. Ho D. D., McKeating J. A., Li X. L., Moudgil T., Daar E. S., Sun N.-C., Robinson J. E. 1991; Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. Journal of Virology 65:489–493
    [Google Scholar]
  13. Jackson D. C., Poumbourios P., White D. O. 1988; Simultaneous binding of two monoclonal antibodies to epitopes separated in sequence by only three amino acid residues. Molecular Immunology 25:465–471
    [Google Scholar]
  14. Kalyan N. K., Lee S. G., Wilhelm J., Pisano M. R., Hum W. T., Hsiao C. L., Davis A. R., Eichberg J. W., Robert-Guroff M., Hung P. P. 1994; Immunogenicity ofrecombinant influenza virus haemagglutinin-carrying peptides from the envelope protein of human immunodeficiency virus type 1. Vaccine 12:753–760
    [Google Scholar]
  15. Kennedy R. C., Henkel R. D., Pauletti D., Allan J. S., Lee T. H., Essex M., Dreesman G. R. 1986; Antiserum to a synthetic peptide recognizes HTLV-III envelope glycoprotein. Science 231:1556–1559
    [Google Scholar]
  16. McLain L., Dimmock N. J. 1994; Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. Journal of General Virology 75:1457–1460
    [Google Scholar]
  17. McLain L., Porta C., Lomonossoff G. P., Durrani Z., Dimmock N. J. 1995; Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Research and Human Retroviruses 11:327–334
    [Google Scholar]
  18. McLain L., Durrani Z., Wisniewski L. A., Porta C., Lomonossoff G. P., Dimmock N. J. 1996a; A plant virus-HIV-1 chimera stimulates antibodies that neutralize HIV-1. In Vaccine 96 pp. 311–316 Brown F., Burton D. R., Collier J., Mekalonos J., Norrby E. Edited by Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  19. McLain L., Durrani Z., Wisniewski L. A., Porta C., Lomonossoff G. P., Dimmock N. J. 1996b; Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14:799–810
    [Google Scholar]
  20. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., Wolf H. 1987; Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates : prediction of antigenic epitopes in conserved and variable regions. Journal of Virology 61:570–578
    [Google Scholar]
  21. Moore J. P. 1993; The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. AIDS Research and Human Retroviruses 9:209–217
    [Google Scholar]
  22. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. 1994a; Mapping the topology of the human immunodeficiency virus glycoprotein gp120 with a panel of monoclonal antibodies. Journal of Virology 68:469–484
    [Google Scholar]
  23. Moore J. P., Cao Y., Conley A. J., Wyatt R., Robinson J., Gorny M. K., Zolla-Pazner S., Ho D. D., Koup R. A. 1994b; Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays. Journal of Acquired Immune Deficiency Syndromes 7:332–339
    [Google Scholar]
  24. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. 1993; A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology 67:6642–6647
    [Google Scholar]
  25. Newton S. M. C., Joys T. M., Anderson S. A., Kennedy R. C., Hovi M. E., Stocker B. A. D. 1995; Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Research in Microbiology 146:203–216
    [Google Scholar]
  26. Pincus S. H., Messer K. G., Schwartz D. H., Lewis G. K., Graham B. S., Blattner W. A., Fisher G. 1993; Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. Journal of Clinical Investigation 91:1987–1996
    [Google Scholar]
  27. Pincus S. H., Messer K. G., Hu S.-L. 1994; Effect of non protective vaccination on antibody response to subsequent human immunodeficiency virus infection. Journal of Clinical Investigation 93:140–146
    [Google Scholar]
  28. Sattentau Q. J., Zolla-Pazner S., Poignard P. 1995; Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206:713–717
    [Google Scholar]
  29. Tisminetzky S. G., Scodeller E. A., Evangelista P., Chen Y., Schiappacassi M., Porro F., Bizik F., Zacchi T., Lunazzi G., Miertus S., Baralle F. E. 1994; Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF: correlation between predicted conformation and antigenicity. FEBS Letters 353:1–4
    [Google Scholar]
  30. Tsoukas C. M., Bernard N. F. 1994; Markers predicting progression of human immunodeficiency virus-related disease. Clinical Microbiology Reviews 7:14–28
    [Google Scholar]
  31. Vella C., Minor P. D., Weller I. V. D., Jenkins O., Evans D., Almond J. 1991; Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. AIDS 5:425–430
    [Google Scholar]
  32. Vella C., Ferguson M., Dunn G., Meloen R., Langedijk H., Evans D., Minor P. D. 1993; Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera. Journal of General Virology 74:2603–2607
    [Google Scholar]
  33. Weiss R. A. 1993; How does HIV cause AIDS?. Science 260:1273–1279
    [Google Scholar]
  34. Wilson I. A., Stanfield R. L. 1993; Antibody-antigen interactions. Current Opinion in Structural Biology 3:113–118
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-11-2709
Loading
/content/journal/jgv/10.1099/0022-1317-79-11-2709
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error